New hope for hidden arthritis: drug trial targets pain without X-Ray signs

This study tests a drug called xeligekimab in 40 adults with non-radiographic axial spondyloarthritis, a form of arthritis that causes back pain but doesn't appear on X-rays. Participants receive six injections over 12 weeks, and doctors check if symptoms improve by at least 20%. After 12 weeks, patients may continue the drug but must pay for it themselves. The goal is to control disease activity, not cure it.